Asian Journal of Psychiatry
Volume 2, Issue 2 , Pages 74-79 , June 2009

Statistical versus clinical significance in psychiatric research—An overview for beginners

Received 28 February 2009 ,Revised 19 March 2009 ,Accepted 9 April 2009.

References 

  1. Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317:1309–1312
  2. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;291(12):1464–1470
  3. Cohen J. Statistical Power Analysis for the Behavioral Sciences. second ed.. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988;
  4. Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver & Boyd; 1925;p. 47
  5. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am. J. Psychiatry. 2004;161(2):217–222
  6. Guaiana G, Barbui C, Hotopf M. Amitryptiline for depression. Cochrane Database Syst. Rev. 2007;(July 18 (3)):Art No.: CD004186
  7. Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641–1651
  8. Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch. Gen. Psychiatry. 2006;63(10):1079–1087
  9. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry. 2002;59(10):921–928
  10. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch. Gen. Psychiatry. 2003;60(1):82–91
  11. Papakostas GI, Thase ME, Fava M, et al. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol. Psychiatry. 2007;62(11):1217–1227
  12. Phutane, V.H., 2009. Randomized double-blind comparison of bifrontal and bitemporal electrode placements in schizophrenia patients referred for ECT. Thesis submitted in partial fulfillment of the regulations of the National Institute of Mental Health and Neurosciences (Deemed University) for the degree of Doctor of Medicine in Psychiatry.
  13. Romeo R, Patel A, Knapp M, et al. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care. Int. Clin. Psychopharmacol. 2004;19(3):125–134

PII: S1876-2018(09)00031-8

doi: 10.1016/j.ajp.2009.04.004

Asian Journal of Psychiatry
Volume 2, Issue 2 , Pages 74-79 , June 2009